Management of the interaction between tacrolimus and nirmatrelvir/ritonavir in the treatment of COVID-19 in solid organ transplantation

被引：0
|
作者：
Leclerc, Vincent [1 ,3 ]
Sanctuaire, Alexandre [1 ]
Chateauvert, Nathalie [1 ,2 ]
机构：
[1] Pneumol Quebec Univ Laval IUCPQ UL, Inst Univ cardiol, Dept Pharm, Quebec City, PQ, Canada
[2] Pneumol Quebec Univ Laval IUCPQ UL, Inst Univ cardiol, Ctr Rech, Quebec City, PQ, Canada
[3] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, 2725 Chemin Se Foy, Quebec City, PQ G1V 4G5, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2023年 / 76卷 / 03期
关键词：
D O I：
10.4212/cjhp.3352
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：254 / 256
页数：3
相关论文
共 50 条
  • [31] Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD
    Hiremath, Swapnil
    McGuinty, Michaeline
    Argyropoulos, Christos
    Brimble, K. Scott
    Brown, Pierre Antoine
    Chagla, Zain
    Cooper, Rebecca
    Hoar, Stephanie
    Juurlink, David
    Treleaven, Darin
    Walsh, Michael
    Yeung, Angie
    Blake, Peter
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (08): : 1247 - 1250
  • [32] VV116 or Nirmatrelvir- Ritonavir for Oral Treatment of Covid-19
    Edwards, Jonathan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25): : 2395 - 2396
  • [33] New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19
    Atmar, Robert L.
    Finch, Natalie
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (08)
  • [34] Nirmatrelvir/ritonavir treatment and risk for postacute sequelae of COVID-19 in older Singaporeans
    Wee, Liang En
    Lim, Jue Tao
    Tay, An Ting
    Chiew, Calvin J.
    Young, Barnaby Edward
    Wong, Betty
    Lim, Ruth
    Li Lee, Ching
    Tan, Joyce
    Vasoo, Shawn
    Lye, David Chien
    Tan, Kelvin Bryan
    CLINICAL MICROBIOLOGY AND INFECTION, 2025, 31 (01) : 93 - 100
  • [35] Clinical Effectiveness of Nirmatrelvir plus Ritonavir in the Treatment of COVID-19 for Patients With Dementia
    Liu, Ting-Hui
    Hsu, Wan-Hsuan
    Tsai, Ya-Wen
    Wu, Jheng-Yan
    Chuang, Min-Hsiang
    Lai, Chih-Cheng
    Huang, Po-Yu
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2023, 24 (08) : 1159 - 1162
  • [36] Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis
    Hsu, Wan-Hsuan
    Shiau, Bo-Wen
    Liu, Ting-Hui
    Wu, Jheng-Yan
    Tsai, Ya-Wen
    Huang, Po-Yu
    Chuang, Min-Hsiang
    Lai, Chih-Cheng
    Chen, Chi-Hsing
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (10) : 1143 - 1151
  • [37] Association between nirmatrelvir/ritonavir treatment and antibiotic prescribing in the outpatient setting among patients with COVID-19
    Caffrey, Aisling R.
    Appaneal, Haley J.
    Lopes, Vrishali V.
    Lavoie, Thomas
    Puzniak, Laura
    Zasowski, Evan J.
    Jodar, Luis
    Arham, Iqra
    Laplante, Kerry L.
    Mclaughlin, John M.
    MICROBIOLOGY SPECTRUM, 2025, 13 (04)
  • [38] Impact of COVID-19 on Solid Organ Transplantation
    Sampson, E.
    Hall, S.
    Robichaux, K.
    Kumar, A.
    Kemmer, N.
    Buggs, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 353 - 354
  • [39] SOLID ORGAN TRANSPLANTATION IN THE COVID-19 PANDEMIC
    Gautier, S. V.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2020, 22 (03): : 6 - 7
  • [40] Clinical effectiveness and safety of simnotrelvir/ritonavir and nirmatrelvir/ritonavir in the treatment of moderate to severe COVID-19 patients
    Shi, Ji Chan
    Chen, Xin
    Lin, Xiao Qing
    Cheng, Fang
    Zheng, Shi Lin
    Zhang, Qiang
    Wu, Te
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
12345